New Drug Elite Club
Tongxieyi, New Drug Elite Club, which founded in October 2012 consists of a Board of Directors and a Secretariat. It is a membership-based club and all individual members have to be senior management personnel or technical experts with proven accomplishments in new drug-related fields; and all corporate members have to be companies engaged in new drug research and development and R&D supporting and investment companies focusing on new drug-related fields with solid financial strength.
This club focuses on gather elites in the new drug R&D field with foresight and sense of mission, explore scientific rule and business models for R&D of new drugs and promote the healthy development of China’s pharmaceutical industry as a non-profit and non-governmental club.
Tongxieyi, New Drug Elites Club serves as a platform for wisdom and emotion communication between medical elites and provides core values including enhancing of the visions of members, establishing mutual trust, solving problems and receiving win-win cooperation. The club helps members to obtain higher wisdom in decision-making, break bottlenecks in technology and management and achieve a sense of belonging and ensure lifelong growth and commercial value with minimum costs in trust and time.